Home Research For Researchers Research Digest Meetings

Upcoming meetings and conferences that are relevant to pancreatic cancer researchers.


2018 CGA Annual Meeting
Oct. 14 – 16, 2018
San Diego, CA
The annual conference will provide critical data and information designed to keep clinicians and scientists up-to-date on new developments in hereditary gastrointestinal cancer research, including implications for physicians, nurses, and genetic counselors to make informed decisions about the prevention, diagnosis, and treatment of patients with hereditary gastrointestinal cancer syndromes. The CGA Annual Conference, in its 22nd year, is the premier conference directed to colorectal surgeons, medical oncologists, gastroenterologists, researchers, geneticists, nurses, colorectal cancer registry coordinators, genetic counselors, psychologists and other professionals involved in the care of individuals with hereditary gastrointestinal cancer, including colorectal, esophageal, pancreatic, gastric, and small bowel cancers.

Mayo Clinic Pancreatic and Hepato-Biliary Cancer Symposium 2018
Oct. 26 – 27, 2018
Scottsdale, AZ
Nationally and internationally renowned faculty provide a state-of-the-art update on the latest treatment options for patients with hepato-biliary and pancreatic cancers. The program is designed to provide a multi-disciplinary overview on the importance of early diagnosis and treatment considerations, including surgery and new pharmacological agents, and how to incorporate these into clinical practice. There will also be a focus on emerging immuno-oncology and molecular profile options.

Pancreas Cancer Symposium: State-of-the-Art 2018 and Beyond
Nov. 30, 2018
Zuckerman Research Center, Memorial Sloan Kettering Cancer Center, New York, NY
This one-day course in conjunction with the Center for Pancreas Cancer Research at Memorial Sloan Kettering is very timely and will review the epidemiology, genomic, molecular and pathologic underpinnings of this disease along with discussing diagnostic and therapeutic approaches for localized, locally advanced and metastatic pancreas adenocarcinoma. An emphasis will be on multidisciplinary decision making and will include a case-based focus. The course will also discuss novel treatments under development and where the field is heading. This course is designed for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, nursing, advanced practice practitioners, trainees and other disciplines.

9th Annual Ruesch Center Symposium: Fighting a Smarter War Against Cancer, Innovations in GI Cancer
Nov. 30 – Dec. 1, 2018
Washington, D.C.
The Ruesch Center for the Cure of Gastrointestinal Cancers will hold its ninth annual symposium divided into three parts. The theme of “Innovations in GI Cancer” will provide a unique forum for discussions on current treatment approaches, cutting-edge research and the pipeline of promising new therapies in GI cancers.

Gastrointestinal Cancers Symposium
Jan. 17 – 19, 2019
San Francisco, CA
Join colleagues from across the globe to discover and share research in treating gastrointestinal cancers. Pancreatic Cancer Action Network will have a booth in the Exhibit Hall.

Pancreas Symposium 2019: Current Controversies in Benign and Malignant Pancreatic Diseases
March 21 – 22, 2019
NewYork Presbyterian/Columbia University Irving Medical Center
The Pancreas Symposium 2019 program will review current controversies and procedures for managing complex pancreatic disease, both benign and malignant. Acute and chronic pancreatitis, pancreatic cystic neoplasms and pancreatic cancer are among the most complex cases that physicians are confronted with as internists, gastroenterologists, oncologists, and surgeons. Their internationally recognized faculty will present lectures and case presentations to help practicing physicians treat pancreatic disease.

NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™
March 21 – 22, 2019
Orlando, FL
The NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ attracts more than 1,600 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer.

AACR Annual Meeting 2019
March 29 – April 3, 2019
Atlanta, GA
The American Association for Cancer Research (AACR) Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.

Gordon Research Conference: Pancreatic Diseases
June 16 – 21, 2019
Newry, ME
The distinctive concept of this Gordon Research Conference (GRC) is to bring together basic and physician scientists at the forefront of research in all aspects of pancreatic diseases, including diabetes, pancreatic cancer and pancreatitis. Specific topics to be explored at this GRC include cell-cell signaling networks and microenvironmental influences on cell behavior, the impact of systemic factors on the pancreatic microenvironment, the role of immune cells in pancreatic diseases, cell plasticity and regeneration, as well as genetic causes of pancreatic cancer and diabetes.


Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.

shop purple logo

Gear, apparel, accessories and more to show off your purple pride.

Shop Now 

©2018 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy

Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.

The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.